Hypertension magnitude and management in the elderly population of Spain

Journal of Hypertension

Volumn 20, Issue 11, 2002, Pages 2157-2164

  Banegas, José R ^a   Rodríguez Artalejo, Fernando ^a   Ruilope, Luis M ^b   Graciani, Auxiliadora ^a   Luque, Manuel ^c   De la Cruz Troca, Juan J ^a   García Robles, Rafael ^d   Tamargo, Juan ^e   Rey Calero, Juan ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e SCHOOL OF MEDICINE   (Spain)

Author keywords

Age; Cross sectional studies; Detection and control; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SALT INTAKE; SEX DIFFERENCE; SPAIN; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; PATIENT EDUCATION; RISK FACTOR; SODIUM RESTRICTION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; HYPERTENSION; MALE; PATIENT EDUCATION; PREVALENCE; RISK FACTORS; SODIUM CHLORIDE, DIETARY; SPAIN;

EID: 0036855496     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200211000-00014     Document Type: Article

References (30)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
2. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17:151-183.
3. Swales JD. Hypertension in the political arena. Hypertension 2000; 35:1179-1182.
4. Markandu ND, Whitcher F, Arnold A, Carney C. The mercury sphygmomanometer should be abandoned before it is proscribed. J Hum Hypertens 2000; 14:31-36.
5. Jones DW, Frohlich ED, Grim CM, Grim CE, Taubert KA, for the Professional Education Committee, Council for High Blood Pressure Research. Mercury sphygmomanometers should not be abandoned: An advisory statement from the council for high blood pressure research, American Heart Association. Hypertension 2001; 37:185-186.
6. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens 1998; 16:971-975.
7. WHO MONICA Project. MONICA Manual. Geneva: World Health Organization; 1990.
8. Leparski E, Nüssel E (editors). World Health Organization, Countrywide Integrated Noncommunicable Diseases Intervention Programme. Protocol and Guidelines for Monitoring and Evaluation Procedures. Berlin: Springer-Verlag; 1987.
9. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
10. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman D, et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11:677-679.
11. Foster C, McKinlay S, Cruickshank JM, Coats AJS. Accuracy of the Omron HEM 706 portable monitor for home measurement of blood pressure. J Hum Hypertens 1994; 8:661-664.
12. Artigao LM, Llavador JJ, Puras A, López J, Rubio MM, Torres C, et al. Evaluación y validación de los monitores Omron Hem 705 CP y Hem 706/711 para automedidas de presión arterial. Aten Primaria 2000; 25:96-103.
13. O'Brien E, Mee F, Tan S, Atkins N, O'Malley K, Training and assessment of observers for blood pressure measurement in hypertension research. J Hum Hypertens 1991; 5:7-10.
14. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32:560-564.
15. Deyo RA, Diehr PD, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controll Clin Trials 1991; 12 (Suppl.):142-158.
16. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37:869-874.
17. Coca A. Evolución del control de la hipertensión arterial en España. Resultados del Estudio Controlpres 98. Hipertensión 1998; 15:298-307.
18. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-91. Hypertension 1995; 25:305-313.
19. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: Results from the health survey for England 1994. J Hypertens 1998; 16:747-752.
20. Prencipe M, Casini AR, Santini M, Ferretti C, Scaldaferri N, Culasso F. Prevalence, awareness, treatment and control of hypertension in the elderly: Results from a population survey. J Hum Hypertens 2000; 14:825-830.
21. Banegas JR, Rodríguez Artalejo F, Cruz JJ, Guallar P, Rey J. Blood pressure in Spain: Distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32:998-1002.
22. Liga Española para la Lucha contra la Hipertensión Arterial. 25 Años de Hipertensión en España. Madrid: Liga Española para la Lucha contra la Hipertensión Arterial, Sociedad Española de Hipertensión, Asociación Española Sociedad Española Liga Española para la Lucha contra la Hipertensión Arterial; 2000.
23. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure: An overview analysis. J Hum Hypertens 1998; 12:91-110.
24. Shah S, Cook DG. Inequalities in the treatment and control of hypertension: Age, social isolation and lifestyle are more important than economic circumstances. J Hypertens 2001; 19:1333-1340.
25. Di Bari M, Salti F, Nardi M, Pahor M, De Fusco P, Tonon E, et al. Undertreatment of hypertension in community-dwelling older adults: A drug-utilization study in Dicomano, Italy. J Hypertens 1999; 17:1633-1640.
26. Coca A. Actual blood pressure control: Are we doing things right? J Hypertens 1998; 16 (Suppl. 1):S45-S51.
27. Perry IJ, Whincup PH, Shaper AG. Environmental factors in the development of essential hypertension. Br Med Bull 1994; 50:246-259.
28. Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: A multicentre study. Bull WHO 2001; 79:490-500.
29. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure. Factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594-599.
30. He J, Bazzano LA. Effects of lifestyle modification on treatment and prevention of hypertension. Curr Opin Nephrol Hypertens 2000; 9:267-271.